Notable Labs
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
320 Hatch Dr, Foster City, California, 9...Phone Number
(408) 713-1104Website
www.notablelabs.comRevenue
<$5 MillionStock Symbol
NTBLIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Notable Labs
Notable Labs is accelerating the process of determining which drugs or combinations are most likely to be effective for groups of blood cancer patients. While most drug companies look to address the largest possible group of patients, Notable looks first for groups with unmet needs and can accurately predict which drugs or drug combinations are likely to have a high success rate there.Explore more
Notable Labs Org Chart
WT
Director Clinical Flow Cytometry
JP
Assistant Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Notable Labs your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Notable Labs launches new products
Congratulate Masked Content for being promoted to Masked Content at Notable Labs
Click to see if Notable Labs had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Notable Labs has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Notable Labs is spiking on competitors!
Check if Notable Labs has recently received funding, and reach out quickly before it becomes old news!
Notable Labs, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Notable Labs recently announced quarterly report
Recommended Actions
Find VP level buyers at Notable Labs
Find 2 more new buyers
Compare Similar Companies to Notable Labs
Compare insights from companies similar to Notable Labs, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Notable Labs
<$5M
11-50
Public
$57.4M
2014
CL
Christopher LeonardiAlliances & Partnerships Head of Commercial
Company Profile Activity
Activity Insights
Notable Labs is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Notable Labs is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Notable Labs.
Notable Labs financials insights
Gather financial insights about Notable Labs, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Angel/Seed
$6M
2016
Other Financing Round
$50K
2017
Series A
$10M
2019
Series B
$40M
2020
Debt
$350K
2021
Debt
$1M
Notable Labs Tech Stack
A closer look at the technologies used by Notable Labs
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Pain Point
Pain Point, Bankruptcy
Promotion
Executive Move
Executive Moves, Promotion
Open Position
Executive Move
Executive Moves, Seeking Replacement
Left Company
Executive Move
Executive Moves, Left Company, Board of Directors
Notable Labs News & Media
Notable Labs to Present Data on September 4th at SOHO 2024
Society of Hematologic Oncology (SOHO) session to highlight volasertib programNotable Labs Announces CEO Transition
Thomas Bock, MD resigns as CEO; Joseph Wagner, PhD, CSO, appointed interim CEONotable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study
Phase 2 dosing plan, agreed with FDA, paves the way to initiate patient enrollment Phase 2 dosing plan, agreed with FDA, paves the way to initiate patient enrollmentNotable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024
FOSTER CITY, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (Nasdaq: NTBL) (“Notable”, “Notable Labs” or the “Company”), a clinical-stage precision oncology company developing new cancer therapies identified by its Predictive Medicine Platform (PMP), today announced that Thomas Bock, M.D., Chief Executive Officer of Notable Labs, will participate in a fireside chat at the Citizens JMP Securities Life Sciences Conference 2024, taking place on May 13-14, 2024, in New York City.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Notable Labs
Sign Up For FreeTo access detailed company insights
Notable Labs is accelerating the process of determining which drugs or combinations are most likely to be effective for groups of blood cancer patients. While most drug companies look to address the largest possible group of patients, Notable looks first for groups with unmet needs and can accurately predict which drugs or drug combinations are lik... Read More
